NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT05134922 2025-03-21Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009Celcuity IncAvailable